Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
When would you offer definitive or adjuvant RT for solitary fibrous tumor or hemangiopericytoma in the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Incompletely resectable or close or positive margins
Sign In
or
Register
to read more
20141
Related Questions
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
How would you approach a patient with synchronous HPV-mediated bilateral tonsil primary with ipsilateral lymph nodes who cannot receive chemotherapy?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How would you manage a presumed radiation induced sarcoma of the head and neck?
How do you approach cisplatin dosing for locally advanced head and neck SCC in HPV-positive and HPV-negative patients?
How would you manage the side effects/toxicities (ex. pain, swelling, erythema) of adjuvant EBRT to the ear for cutaneous SCC?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
Would you recommend adjuvant radiation for a patient with head/neck merkel cell carcinoma following a pathologic complete response to neoadjuvant immunotherapy?